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Background: Biobanks are a critical resource for translational science. Recently, semantic web technologies such as
ontologies have been found useful in retrieving research data from biobanks. However, recent research has also
shown that there is a lack of data about the administrative aspects of biobanks. These data would be helpful to
answer research-relevant questions such as what is the scope of specimens collected in a biobank, what is the
curation status of the specimens, and what is the contact information for curators of biobanks. Our use cases
include giving researchers the ability to retrieve key administrative data (e.g. contact information, contact's
affiliation, etc.) about the biobanks where specific specimens of interest are stored. Thus, our goal is to provide an
ontology that represents the administrative entities in biobanking and their relations. We base our ontology
development on a set of 53 data attributes called MIABIS, which were in part the result of semantic integration
efforts of the European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI). The previous work
on MIABIS provided the domain analysis for our ontology. We report on a test of our ontology against competency
questions that we derived from the initial BBMRI use cases. Future work includes additional ontology development
to answer additional competency questions from these use cases.
Results: We created an open-source ontology of biobank administration called Ontologized MIABIS (OMIABIS) coded
in OWL 2.0 and developed according to the principles of the OBO Foundry. It re-uses pre-existing ontologies when
possible in cooperation with developers of other ontologies in related domains, such as the Ontology of
Biomedical Investigation. OMIABIS provides a formalized representation of biobanks and their administration. Using
the ontology and a set of Description Logic queries derived from the competency questions that we identified, we
were able to retrieve test data with perfect accuracy. In addition, we began development of a mapping from the
ontology to pre-existing biobank data structures commonly used in the U.S.
Conclusions: In conclusion, we created OMIABIS, an ontology of biobank administration. We found that basing its
development on pre-existing resources to meet the BBMRI use cases resulted in a biobanking ontology that is re-useable
in environments other than BBMRI. Our ontology retrieved all true positives and no false positives when queried
according to the competency questions we derived from the BBMRI use cases. Mapping OMIABIS to a data structure
used for biospecimen collections in a medical center in Little Rock, AR showed adequate coverage of our ontology.* Correspondence: mbrochhausen@uams.edu
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Biobanks are a critical resource in translational science,
such as translational oncology, as they provide speci-
mens essential to the identification of novel biomarkers
for specific therapies [1]. Recent research has provided
compelling examples of using semantic web technolo-
gies, such as ontologies, to retrieve research-relevant
data from biobanks [2,3]. However, [4] point out that
little attention is paid to collecting data about the dif-
ferent ways in which biobanks are organized. This lack
is apparent in both of the ontologies considered by the
authors of [2,3]: Neither the Ontology of Biomedical
Investigation (OBI)a, nor the Translational Medicine
Ontology (TMO)b represent biobanks, biobank orga-
nizations, or related entities. This situation makes it
impossible to query biobanks with respect to orga-
nizational structures, ownership of biobanks and speci-
mens, and the curation status of specimens. Thus, our
goal was to provide an ontology that represents the
administrative aspects of the biobanking domain to
enable querying biobank data from both the specimen
or population perspective and the administrative pers-
pective. Our ontology is called Ontologized MIABIS
(OMIABIS) and is named after the Minimum Informa-
tion About BIobank data Sharing (MIABIS) [5]. The
latter provided the starting point for our ontology de-
velopment. We recently released the initial version of
OMIABIS coded in Web Ontology Language 2.0. It can
be downloaded from http://purl.obolibrary.org/obo/
omiabis.owl. The ontology is open source and we invite
the community to develop it further with us.
In the background section we introduce MIABIS and
its use cases. In the methods section we describe our
approach to ontology development including the re-use
of existing ontologies. In addition, we introduce our
approach to testing the ability of the ontology to an-
swer competency questions derived from our use cases.
In the results section, we show the basic features of our
ontology and present the results of our evaluation of its
adequacy. Finally, we discuss future work and potential
uses of the ontology, as well as its connections to
ongoing efforts in biomedical ontology.
Background
Introducing BBMRI
For an initial domain analysis we relied on the work on
data integration done by the European Biobanking and
Biomolecular Resources Research Infrastructure (BBMRI).
During the so-called preparatory phase of BBMRI, be-
tween 2008–2011, the initiative comprised 54 different
partners across Europe and more than 225 associated
organizations representing over 30 countries. One of the
aims of the BBMRI is to provide the necessary formats to
compare biobank information at different levels of detail[6]. Work on data integration within BBMRI used at
least two approaches; a survey of the samples and data
of European biobanks using questionnaires—resulting
in the Catalogue of European Biobanks [7], and the de-
velopment of a common information model for a hub-
and-spokes structure for national or regional biobank
nodes [8]. Because biobank data is often related to per-
sonal health data, management and sharing must fol-
low legal jurisdiction, according to Directive 95/46/EC
in the European context. In combination with several
other integration issues identified in [9], the establish-
ment of an information model for sharing biobank data
on an international level will require future effort. In
the meantime, and to meet the demand of the biobank
community to understand what data should be stored
in relation to biological samples, a minimum list of
data attributes was drafted as one of the last activities
in the preparatory phase of BBMRI. One of the activ-
ities in the Swedish BBMRI, i.e., BBMRI.se, has been to
continue the development of the minimum information
list from the European BBMRI. The updated version is
called MIABIS – Minimum Information About BIo-
bank data Sharing – and consists of fifty-two attributes
considered important for establishing a system of data
discovery for biobanks and sample collections. To
avoid legal issues related to individual subjects, cases
or samples are not considered at present [5]. The attri-
butes employ existing standards, e.g., the Sample
PREanalytical Code (SPREC) [10], ICD Codesc, and
definitions developed by the Public Population Project
in Genomics (P3G)d and the International Society for
Biological and Environmental Repositories (ISBER)e.
Use cases for MIABIS & OMIABIS
MIABIS was developed in the context of several use
cases described by invited researchers as part of the
BBMRI project. Our two example use cases stem from
the development of MIABIS:
a) Search for tissue samples from donors diagnosed
with nemaline myopathy. Determine the age group.
What are the sample storage conditions? Contact
the biobank for detailed information about the
biopsy samples and whether myoblast cell cultures
have been grown from these samples.
b) Search for sample collections having at least 10
cases with tissue from the thoracic aorta as well
as blood, serum, or plasma from the same
donor. Also check if clinical data has been
registered for the donors such as physical
measurements. Contact the person responsible
for the sample collection to obtain detailed
information on the specific kind of thoracic
aorta biopsies of interest. Also assure that the
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relation to the blood sampling.
Use case b) would require inclusion of individual-
level data. As mentioned above, the attributes for
representing data about individual donors and speci-
mens were dropped during MIABIS development due
to regulatory issues.
Already, MIABIS is being used in a structured Scandi-
navian survey to gather information about sample col-
lections stored in biobanks in a searchable database
(www.bbmriregister.se). Increasing the total searchable
information could include uploading new data directly
to the existing system, and/or developing external data-
bases that structure the information according to MIABIS.
In the latter case, an ontologized version of MIABIS will
be used to perform a federated search across the multiple
databases. This search capability will minimize the effort a
researcher must expend to search for sample collections of
interest, by avoiding the need to query several separate da-
tabases one by one. Hence, the University of Arkansas for
Medical Sciences and Karolinska Institutet, representing
BBMRI.se, decided to initiate a biobank ontology develop-
ment project as a joint effort.
Methods
Our aim is to provide a semantically rich representa-
tion of biobank administration to facilitate the sharing
of biobank data. We based our development on an ana-
lysis of the minimum requirements for sharing biobank
data done within the BBMRI as captured by MIABIS.
Hence, we named our ontology OMIABIS, standing for
Ontologized MIABIS. To make the ontology easily ac-
cessible and implementable, we chose Web Ontology
Language (OWL) 2 [11] for implementation. To facili-
tate re-use and harmonization across ontologies, we
used Basic Formal Ontology (BFO)f as the upper ontol-
ogy [12,13]. In addition, the entire ontology develop-
ment followed the principles of ontology development
as set forth by the OBO Foundry [14]g.
Re-use of preexisting ontologies is key among the
OBO Foundry principles. In creating OMIABIS we
imported the Proper Name Ontology (PNO)h in its en-
tirety. PNO is based on the Information Artifact Ontol-
ogy (IAO)i. It is a formal representation of proper names
based on Devitt's theory of designation [15]. Thus,
OMIABIS is an extension of IAO. In addition, multiple
entities from other ontologies, namely the Ontology of
Biomedical Investigations (OBI)j and the Ontology of
Medically Relevant Social Entities (OMRSE)k are im-
ported using a tool based on the MIREOT methodology
[16], which was developed in a joint endeavor between
the University of Arkansas for Medical Sciences and the
University of Arkansas at Little Rock [17].We chose to re-use the ontologies mentioned above
based on the fact that they are members of the OBO
Foundry and, thus, are built according to the same basic
principles and extend the same upper ontology (BFO).
Our aim is to create ontological representations that
facilitate the integration of biobank administrative data
with biomedical research data. The latter often is anno-
tated with terms from Gene Ontology (GO) or OBI.
Thus, choosing ontologies from the very same orthog-
onal ontology library (OBO Foundry) of which the latter
are members appears to be the best strategy to accom-
plish this integration.
All directly imported ontologies (BFO, PNO, IAO) will
update automatically. MIREOT, so far, does not have a
strategy for automated updates. However, the developers
of the MIREOT plugin plan to include this functionality
in a future release.
In addition to these ontologies, the development of
OMIABIS was informed by other pre-existing ontologies
in the biobanking domain mentioned in the Discussion
section of this paper.
Because existing ontologies already represent speci-
mens, clinical studies and populations, OMIABIS repre-
sents the domain of biobank administration. Together
with terms from these specimen-focused ontologies,
OMIABIS needs to allow the level of semantic integra-
tion required by the use cases described above.
OMIABIS was developed using Protégé 4.1.0, Build 239l.
The MIREOT Plugin is Version 1.0.1. The consistency of
our ontology was verified using the HermiT 1.3.6 reasonerm.
To test the adequacy of our ontology for the BBMRI
use cases (s. Background section) we derived a set of com-
petency questions from them. Because the focus of the
ontology is the administrative aspects of biobanks, the use
cases entail some competency questions that fall outside
the scope of our ontology at this point (namely all ques-
tions related to the different donor subpopulations).
The competency questions we address and evaluate
here are:
 Which biobanks hold frozen specimens?
 Which biobanks hold blood, plasma and serum?
 Which blood plasma specimens are owned by one
specific biobank organization?
 Which departments of a specific university have
members that are serving as biobank contacts?
 What are the e-mail addresses of all biobank contact
persons at one specific biobank organization?
These competency questions were approved by the
domain experts from Karolinska Institute.
To perform DL queries that test the adequacy of the
ontology to retrieve data that answer the competency
questions, we populated an OWL file (that imports
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up biobank example. In OWL it is possible to represent
the individual members of classes. OMIABIS per se
does not represent any individuals, but it imports 326
individuals from GEO that represent nations and their
administrative subdivisions (to enable capture of the
mailing addresses of biobank contacts). We included
both true positives and false positives to the instance-
level OWL file, to ensure that queries did not retrieve
incorrect information. This file is called CompetencyTest.
owl, and can be downloaded from: http://omiabis-dev.
googlecode.com/svn/branches/CompetencyTest.owl. In
addition, we submitted the file to this journal as
Additional file 1.
The actual queries we ran together with the results
can be found in Table 1.
Results
Implementation of OMIABIS
The latest release of OMIABIS in OWL can be down-
loaded from the permanent URL http://purl.obolibrary.
org/obo/omiabis.owl. In our research we focused on
representing the MIABIS data attributes focused on
biobanks and studies/sample collections, which com-
prises all classes and object properties closely related to
administrative aspects.
The central class of any biobank ontology ought to be
the class of biobanks or biorepositories. MIABIS differ-
entiates biobanks from the organizations that own them.
Accordingly, OMIABIS defines "biobank" as follows: "A
biobank is a collection of samples of biological sub-
stances (e.g. tissue, blood, DNA) which are linked to
data about the samples and their donors. They have a
dual nature as collections of samples and data." The def-
inition is derived from the definition for human biobank
in [18]. The latter does not define "biobank” in general,
but we generalized their definition to be applicable to
any kind of biobank. The class is formally restricted to
be the equivalent ofn:
Notably, the biobank as such is neither an organization
nor a facility, but the aggregate of the specimens and the
data regarding these specimens. OMIABIS also represents"biobank organization". Its textual definition is: "A biobank
organization is an organization bearing legal personality
that owns or administrates a biobank". "Biobank orga-
nization" is equivalent to:
Referring to the class "legal person role" from
OMRSE is necessary due to the fact that the definition
of organization in OBI does not refer to legal
personalityp. Any group of human beings that has
some organizational rules fulfills the textual definition
according to OBI. However, for our use case legal per-
sonality is crucial, since within the BBMRI framework
we are concerned with management of certain rights
and obligations, which are held by legal persons. The
formal description of biobank organization uses two
object properties which have been specifically created
for OMIABIS:
1. "owns"
Elucidation: This is a primitive relation. This relation
is the foundation to the owner’s right to have the owned
entity at his/her full disposal.
Domain: Homo sapiens
OR organization
OR collection of humans
OR aggregate of organizations
Range: information content entity
OR material_entity
Characteristics: asymmetric
The elucidation for this primitive relation is based on
Reinach's legal ontology [19]. For further material on the
ontology of claims and obligations see [20].
2. "administrates"
Definition: "a administrates b if c owns b and some
rights and obligations grounded in the owning relation
regarding b are transferred[q] from c to a."
Domain: Homo sapiens
OR organization
OR collection of humans
OR aggregate of organizations
Range: information content entity
OR material_entity
Characteristics: asymmetric
OMIABIS includes a total of 249 classes and 64 object
properties. Of the 249 classes 34 classes are restricted
by an equivalent class axiom. 35 classes and object
properties were newly created for the initial version of
Table 1 DL Queries executed on the Competency Test OWL file and results
Competency question DL Query Recall Precision Ratio Reasoning
time (in ms)
Which biobanks hold frozen specimens? biobank and has_part some 'frozen specimen' 100% 100% 6/6 76.9
Which biobanks hold blood, plasma
and serum?
biobank and has_part some 'blood plasma specimen' and
has_part some 'blood serum specimen' and has_part some
'blood specimen'
100% 100% 5/5 53.2
Which blood plasma specimens are owned
by one specific biobank organization?
'blood plasma specimen' and part_of some (biobank and 'is
owned by' some {'Unseen University'})
100% 100% 6/6 45.4
Which departments of a specific university
have members that are serving as
biobank contacts?
department and 'has organization member' some (bearer_of
some 'biobank contact role')
100% 100% 6/6 30.2
What are the e-mail addresses of all
biobank contact persons at one specific
biobank organization?
'email address' and 'is contact information about' some
(bearer_of some 'biobank contact role' and 'is member of
organization' some {'Unseen University'})
100% 100% 6/6 55.2
Each query is encoded in a separate test method in Scala using the Java OWL-API. Each method reloads the ontology, builds the necessary axiom from API calls,
adds the axiom, executes the query, and removes the axiom from the ontology. Each trial was conducted by running each method 100 times and reporting the
average running time in milliseconds. Ten trials were conducted.
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created classes and object properties. Figure 1 shows a
semantic network for the central classes of OMIABIS
and how they are used in retrieving data matching the
competency questions.
The OMIABIS labels tend to be very long, since they
are referring to the ontological hierarchy. However, we
foresee that for future use cases we might add more and
shorter labels for those classes to accommodate devel-
opers and users. In OMIABIS the MIABIS attributes are
given as "alternative name" for the class in question.
Performance of OMIABIS regarding the competency
questions
Table 1 shows the DL queries we executed using the DL
query tab of Protégé and their results. The test ontology
based on OMIABIS and populated with example individ-
uals performed flawlessly in answering the competency
questions as specified in the Methods section.
Discussion
OMIABIS in relation to pre-existing efforts in
biobank ontology
Ontologies have been identified as a key technology to
overcome the lack of semantic integration of biobank-
related data [21]. [3] demonstrates how pre-existing on-
tologies, namely the Ontology of Biomedical Investiga-
tion (OBI) [22] and BioTop [23] can be efficiently used
to represent data regarding samples and sample curation
in a semantically rich way. The methodology used, and
the criteria applied, by [3] overlap with our approach to
ontology development. In our research we focused on
administrative data regarding biobanks, sample collec-
tions, and studies producing sample collections, whereas
[3] focuses on individual specimens or samples. We plan
to use a similar approach and integrate their work in sub-
sequent research that will address the issue of propertiesof individual samples [24]. Developed an ontology-based
architecture to integrate data from heterogeneous
biobanks by unifying metadata. Since the outcome of their
development is not open source, we contacted the devel-
opers and aim to cooperate with them on the OMIABIS
project.
Another ontology that represents biobanks/biorepo-
sitories is the eagle-i resource ontology (ERO)r, which was
created for the eagle-i project. The aim of the eagle-i pro-
ject is to "create a searchable inventory of unique, rare or
otherwise hard-to-find biomedical resources … to foster
sharing and linking of resources in the larger scientific
community". ERO is used to integrate data about biomed-
ical resources and make the search functionality more
flexible [25]. However, due to its use case ERO is relatively
sparse with respect to axiomatic representation of its clas-
ses. Our goal was to provide a semantically rich ontology
that allows extensive reasoning, so re-use of ERO classes
was not an option. In addition, we found ambiguities and
lack of clarity in its representation of biobanks, specifically
the fact that it defines biobank organization instead of
biobank.. We have since begun collaborating with the
ERO developers on the branches of ERO related to
biobanks and their management.
Performance of OMIABIS regarding the competency
questions
The fact that all true positives were retrieved and none of
the false positives was, hints to the fact that the ontology
performs well. Based on our timing results when running
the queries, we suspect that the axiomatic definition of
"biobank" (given in Results section) is computationally
"expensive". Relatively simple queries that used this class
ran slower that complex queries that did not refer to it.
We are aware that the number of individuals in the
competency test ontology is small. Both (1) the initial
use cases from BBMRI and (2) the usage of OMBIABIS
Figure 1 Illustration of the central OMIABIS classes. The figure shows the central classes of OMIABIS and the object properties connecting
them. Light blue rectangles are classes; light blue arrows are object properties. Dark blue circles and edges represent instances that can be
retrieved using OMIABIS.
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in multiple databases. This raises the question of how the
ontology will be used to query across large data sets. Our
scenarios focus on researchers retrieving data about pos-
sible sources of specimens (BBMRI) or specific specimens
(i2b2) to do research. This task is part of a study's plan-
ning phase. It is not related to patient-related activities or
the performance of lab work. Thus, we believe, it is rea-
sonable to provide the researcher with the benefit of a fed-
erated search at the cost of speed. The query results could
be sent to the researcher once they are available. There
does not seem to be the need for immediate recall. None-
theless, we do want to keep reasoning time to a minimum
once we start running queries on large data sets. We
therefore plan to implement or develop methods to
ensure timely recall.
Ontological challenges regarding the MIABIS attribute
"biobank type"
Taking into consideration the immediately biobank-
related attributes in MIABIS, we found one attribute to be
challenging from the perspective of ontology develop-
ment: biobank type. Among the values for this attribute in
MIABIS are for example Pathology, Cytology, Gynecology
etc. There are strong indications from MIABIS users that
this list is not exhaustive. The rationale behind this attri-
bute and its current values is to allow the person submit-
ting data about a biobank to easily select something that
seems plausible to her. However, the downside of this ap-
proach is a certain difficulty for end users to find relevant
biobanks and studies for her research. The possible values
for biobank type in MIABIS are under elaboration andwill be updated as time progresses. A particular specimen
collection, by virtue of the type of specimens stored,
might be of interest to both pathologists and virologists,
or gynecologists and cytologists, and so on. In order to
provide useful ontological representation of these classes
we need users to specify which characteristics of a
biobank make it useful for which specialty of medicine or
which research domain.
Using OMIABIS to annotate data in i2b2
In addition to putting OMIABIS to use within the BBMRI
framework, we plan to use it for biobank data manage-
ment at University of Arkansas for Medical Sciences
(UAMS) and the Arkansas Children’s Hospital Research
Institute (ACHRI). UAMS has a Tissue Procurement
Facility and several, relatively smaller individual research
labs (i.e. the Myeloma Institute, the "Spit for the Cure"
Project). In addition, ACHRI has several independent labs
similarly managing specimens, including the Center
for Birth Defects Research, Section of Developmental-
Behavioral and Rehabilitative Pediatrics (autism research),
and the Women's Mental Health Program. Both UAMS
and ACHRI would like to share their collected specimens
and annotated data for research purposes while keeping
the operations of each lab independent. Recently, UAMS
created an Enterprise Data Warehouse (EDW) to facilitate
access to and integration of clinical, basic-science, and
other data for research and quality reporting. Retrieving
de-identified data from the EDW is done using Informa-
tics for Integrating Biology and the Bedside (i2b2) [26,27],
an open-source software application. i2b2 was designed
primarily for cohort identification, allowing users to
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patients meeting certain inclusion or exclusion criteria.
Researchers have requested adding the ability to search
for specimens to the data warehouse.
To ensure semantic integration of data from multiple
biobanks with research relevant patient data, i2b2 requires
an ontology to which the data will be mapped in i2b2's
Ontology Cell. Because the management, the operations,
and the data collected in the biobanks are heterogeneous,
manual mapping of the data into a single i2b2 instance is
a challenge. Instead, a federated architecture where quer-
ies are distributed to individual nodes and the results
merged is the more promising approach. This approach
requires a common ontology like OMIABIS.
Currently the biobanks at UAMS use caTissue [28], an
open-source biospecimen management tool. caTissue is
developed under the cancer Biomedical Informatics Grid
(caGRID) initiative of the National Cancer Institute (NCI).Figure 2 Mapping between OMIABIS classes and caTissue data elemeIt facilitates the process of locating and analyzing tissue
specimens by cancer researchers based on clinical, tissue,
and genomic characteristics. caTissue Annotation forms
store clinical and other related data about specimens. Also
called Dynamic Extensions, this component allows the
creation of new forms that contain fields a site wishes to
collect about each specimen.
Despite using a single software application, integration
of data is not guaranteed in this approach because each
biobank creates its own specimen annotation forms with
different data elements. To ensure and optimize seman-
tic integration, we will incorporate an ontology into
caTissue’s annotation forms for all UAMS/ACHRI bio-
banks and the biobank administration data model. Then,
the data in separate caTissue instances for the biobanks
can be easily incorporated into the EDW i2b2 instance,
and queried with common semantics. The researchers run-
ning the EDW have identified OMIABIS as the ontology itnts.
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OMIABIS terms to caTissue data elements previously used
by UAMS' EDW.
McCusker et al. [29] have studied an option that would
convert NCIt curated Unified Modelling Language (UML)
annotations to OWL using semCDI. semCDI query for-
mulation uses a view of caBIG semantic concepts, meta-
data, and data as an ontology [30]. The result was that
OWL annotation properties are used to represent meta-
data on OWL constructs and are not considered for rea-
soning purposes. So, McCusker et al. have indeed created
their own UML-to-OWL transformation that does not
model attributes as datatype properties and does not
model NCIt annotations of UML classes using subsump-
tion. This methodology limits the expressivity and limits
reasoning ability. In addition, this approach did not
consider multiple biobanks.
To fulfill all requirements of biobank data integration
within the UAMS/ACHRI framework, in the future
OMIABIS representations will need to be integrated with
ontologies representing individual specimens and donors.
Our next step is to cooperate with other biobank pro-
jects and biobank ontologies to extend OMIABIS and to
work towards a domain ontology for biobanking as a
whole. OMIABIS will be curated and maintained as an
open-source artifact using subversion on an ongoing
basis, with periodic releases of new versions.Conclusions
In conclusion, we created OMIABIS, an ontology of
biobank administration. We found that basing its devel-
opment on pre-existing resources to meet the BBMRI
use cases resulted in a biobanking ontology that is
re-useable in environments other than BBMRI.. With re-
spect to answering the competency questions, our quer-
ies against an OMIABIS-based ontology, populated with
a small set of hypothetical test cases, retrieved only true
positives and did not miss any true positives. In addition,
the mapping to a pre-existing data structure in the
open-source caTissue application used for biospecimen
collections in a medical center in Little Rock, AR dem-





dThe Public Population Project in Genomics (P3G):
http://www.p3g.org.
eThe International Society for Biological and Environ-
mental Repositories (ISBER): http://www.isber.org.
fBasic Formal Ontology (BFO): http://ifomis.org/1.1gPrinciples of the OBO Foundry: http://obofoundry.
org/crit.shtml
hThe Proper Name Ontology (PNO): http://purl.
obolibrary.org/obo/iao/pno.owl
iThe Information Artifact Ontology (IAO): http://purl.
obolibrary.org/obo/iao.owl
jThe Ontology of Biomedical Investigation (OBI):
http://purl.obofoundry.org/obo/obi.owl
kThe Ontology of Medically Related Social Entities
(OMRSE): http://purl.obolibrary.org/obo/omrse.owl
lThe Protégé Ontology Editor and Knowledge Acquisi-
tion System: http://protege.stanford.edu
mHermiT Reasoner: http://www.hermit-reasoner.com
nclasses printed bold, object properties in italics and
OPERATORS all caps. Definitions of classes referred to
here can be found in Table 1
oNote that this class description is based on object
properties and classes from BFO, IAO and OBI.
phttp://purl.obolibrary.org/obo/OBI_0000245
qThe 'transfers' object property is represented in
Document Acts Ontology (d-acts): http://purl.obolibrary.
org/obo/iao/d-acts.owl
rThe eagle-i Resource Ontology (ERO): http://purl.
obolibrary.org/obo/ero.owl
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